|
|
||||||||
The Journal of Immunology, Vol 155, Issue 9 4454-4458, Copyright © 1995 by American Association of Immunologists
ARTICLES |
K Pazdrak, L Justement and R Alam
University of Texas Medical Branch, Department of Internal Medicine, Galveston 77555, USA.
The activation of eosinophils by IL-5 plays a crucial role in the pathogenesis of allergic and parasitic disorders. IL-5 has recently been shown to activate Lyn and Jak2 tyrosine kinases, MAP kinases, and STAT1 nuclear factor. We have previously reported that TGF-beta blocks the IL-5-induced activation of eosinophils. In this study, we investigated the effect of TGF-beta on the IL-5-induced signaling molecules in eosinophils. Purified eosinophils from mildly allergic patients were preincubated with TGF-beta and then stimulated with IL-5. The cell lysates were then immunoprecipitated and blotted with antiphosphotyrosine Abs. The activity of the kinases was further studied in the immune-complex kinase assay. We found that TGF-beta inhibited the tyrosine phosphorylation of multiple proteins in eosinophils. The identity of some of the proteins was established by immunoprecipitation. We found that TGF-beta inhibited tyrosine phosphorylation of Lyn, Jak2, and a 44-kDa MAP kinase. In further experiments, it blocked the activation of the above kinases as determined by immune-complex kinase assay. TGF-beta also inhibited phosphorylation of the STAT1 (p91) nuclear protein in eosinophils. We believe that the inhibition of Lyn, Jak2, MAP kinase, and the STAT1 nuclear protein may underlie the inhibitory activity of TGF-beta on eosinophils.
This article has been cited by other articles:
![]() |
N. Goplen, M. M. Gorska, S. J. Stafford, S. Rozario, L. Guo, Q. Liang, and R. Alam A Phosphosite Screen Identifies Autocrine TGF-{beta}-Driven Activation of Protein Kinase R as a Survival-Limiting Factor for Eosinophils J. Immunol., March 15, 2008; 180(6): 4256 - 4264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fattouh, N. G. Midence, K. Arias, J. R. Johnson, T. D. Walker, S. Goncharova, K. P. Souza, R. C. Gregory Jr., S. Lonning, J. Gauldie, et al. Transforming Growth Factor-{beta} Regulates House Dust Mite-induced Allergic Airway Inflammation but Not Airway Remodeling Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 593 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Bollard, C. Rossig, M. J. Calonge, M. H. Huls, H.-J. Wagner, J. Massague, M. K. Brenner, H. E. Heslop, and C. M. Rooney Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity Blood, May 1, 2002; 99(9): 3179 - 3187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Q. Xiao, K. Malcolm, G. S. Worthen, S. Gardai, W. P. Schiemann, V. A. Fadok, D. L. Bratton, and P. M. Henson Cross-talk between ERK and p38 MAPK Mediates Selective Suppression of Pro-inflammatory Cytokines by Transforming Growth Factor-beta J. Biol. Chem., April 19, 2002; 277(17): 14884 - 14893. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Huang, C.-J. Huang, and J. J.-Y. Yen Mcl-1 is a common target of stem cell factor and interleukin-5 for apoptosis prevention activity via MEK/MAPK and PI-3K/Akt pathways Blood, September 1, 2000; 96(5): 1764 - 1771. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, T. Town, M. Saxe, D. Paris, Y. Wu, and M. Mullan Ligation of Microglial CD40 Results in p44/42 Mitogen-Activated Protein Kinase-Dependent TNF-{alpha} Production That Is Opposed by TGF-{beta}1 and IL-10 J. Immunol., December 15, 1999; 163(12): 6614 - 6621. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kankaanranta, P. M. De Souza, P. J. Barnes, M. Salmon, M. A. Giembycz, and M. A. Lindsay SB 203580, an Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances Constitutive Apoptosis of Cytokine-Deprived Human Eosinophils J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 621 - 628. [Abstract] [Full Text] |
||||
![]() |
E. M. Coccia, N. D. Russo, E. Stellacci, U. Testa, G. Marziali, and A. Battistini STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules Int. Immunol., July 1, 1999; 11(7): 1075 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sudarshan, J. Galon, Y.-j. Zhou, and J. J. O'Shea TGF-{beta} Does Not Inhibit IL-12- and IL-2-Induced Activation of Janus Kinases and STATs J. Immunol., March 1, 1999; 162(5): 2974 - 2981. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.G. Begley and N.A. Nicola Resolving Conflicting Signals: Cross Inhibition of Cytokine Signaling Pathways Blood, March 1, 1999; 93(5): 1443 - 1447. [Full Text] [PDF] |
||||
![]() |
C. Pardoux, X. Ma, S. Gobert, S. Pellegrini, P. Mayeux, F. Gay, G. Trinchieri, and S. Chouaib Downregulation of Interleukin-12 (IL-12) Responsiveness in Human T Cells by Transforming Growth Factor-beta : Relationship With IL-12 Signaling Blood, March 1, 1999; 93(5): 1448 - 1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Uzgare, J. A. Uzman, H. M. El-Hodiri, and A. K. Sater Mitogen-activated protein kinase and neural specification in Xenopus PNAS, December 8, 1998; 95(25): 14833 - 14838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, Y. Sun, and G. J. Nabel Regulation of the Proinflammatory Effects of Fas Ligand (CD95L) Science, November 27, 1998; 282(5394): 1714 - 1717. [Abstract] [Full Text] |
||||
![]() |
T. K. Sengupta, E. S. Talbot, P. A. Scherle, and L. B. Ivashkiv Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases PNAS, September 15, 1998; 95(19): 11107 - 11112. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi and R. Alam The mechanism of IL-5 signal transduction Am J Physiol Cell Physiol, September 1, 1998; 275(3): C623 - C633. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bright and S. Sriram TGF-{beta} Inhibits IL-12-Induced Activation of Jak-STAT Pathway in T Lymphocytes J. Immunol., August 15, 1998; 161(4): 1772 - 1777. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pazdrak, B. Olszewska-Pazdrak, S. Stafford, R. P. Garofalo, and R. Alam Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and Degranulation J. Exp. Med., August 3, 1998; 188(3): 421 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-U. Simon, S. Yousefi, B. Dibbert, H. Hebestreit, M. Weber, D. R. Branch, K. Blaser, F. Levi-Schaffer, and G. P. Anderson Role for Tyrosine Phosphorylation and Lyn Tyrosine Kinase in Fas Receptor-Mediated Apoptosis in Eosinophils Blood, July 15, 1998; 92(2): 547 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ogata, T. Kouro, A. Yamada, M. Koike, N. Hanai, T. Ishikawa, and K. Takatsu JAK2 and JAK1 Constitutively Associate With an Interleukin-5 (IL-5) Receptor alpha and beta c Subunit, Respectively, and Are Activated Upon IL-5 Stimulation Blood, April 1, 1998; 91(7): 2264 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Amsterdam and N. Selvaraj Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes Endocr. Rev., August 1, 1997; 18(4): 435 - 461. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |